A recent New York Times article helps highlight just how far behind insurance companies are to innovations of modernity and innovation. Highlighting the cases of several cancer patients who were forced to go out-of-pocket to receive convenient oral treatments rather than in-house intravenous, etc., care, the NYT highlights how insurance companies rely on redtape and a lack of federal demand to innovate to demonstrate how the average citizen who, until they fall into crisis, believe they are fully covered suddenly are required to provide their own money for reasonable remedy:
Pills and capsules are the new wave in cancer treatment, expected to account for 25 percent of all cancer medicines in a few years, up from less than 10 percent now.
The oral drugs can free patients from frequent trips to a clinic to be hooked to an intravenous line for hours. Fewer visits might save the health system money as well as time. And the pills are a step toward making cancer a manageable chronic condition, like diabetes.